ArticleMolecular neurobiology2025
Altered Expression of Large Amino Acid Transporter (LAT1) and Branched-Chain Metabolic Enzymes in the Type 1 Diabetic Rat Retina.
Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Expression and Localization of Branched-Chain Ketoacid Dehydrogenase E1 Subunits and LAT1 Transporter in Rat Retinal and Ocular Tissues.Neurochemical research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Diabetic retinopathy (DR) is a significant complication of diabetes that results in retinal damage and the risk of blindness. Branched-chain amino acids (BCAAs) are essential amino acids that fulfill physiological roles in energy balance and neurotransmitter regulation within the retina. While high levels of BCAAs are associated with DR, their metabolism in DR remains poorly understood. This study investigated the mechanisms underlying increased BCAA levels and their role in DR using STZ-diabetic rats (4 and 8 weeks). We measured mRNA (qPCR), protein (immunoblotting/immunofluorescence), and biochemical markers (BCAA and oxidative stress). Results showed elevated BCAA levels in both the serum and the retinas of diabetic rats at 4 and 8 weeks versus controls. Large amino acid transporter (LAT1), branched-chain amino acid transferase (BCATs), and branched-chain keto dehydrogenase α subunit (BCKDE1α) mRNA levels remained significantly unchanged, while BCKDE1β subunit was notably affected by diabetes. The protein expression of BCAT1 significantly decreased in the diabetic retina after 4 and 8 weeks of diabetes. LAT1 expression increased after 8 weeks compared to 4-week diabetic rats, but this change was insignificant. The protein expression of BCAT2 and BCKDE1 subunits did not change significantly due to diabetes. Additionally, the expression levels of neurotrophic factors (BDNF), antioxidant (GSH), and glutamine synthase (GS) were lower in diabetic retinas compared to controls. In contrast, TBAR and apoptosis factors (caspase 3 and BAX) were increased in diabetic retinas. These findings suggest that increased LAT1 expression and decreased BCAT1 protein in the diabetic retina contribute to elevated BCAA levels. Together with reduced GS expression, increased oxidative stress and apoptosis may lead to neuronal damage and retinal neurodegeneration in DR, indicating the significance of altered BCAA metabolism in DR progression.
Indexed as
Identifiers
41317256What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.